Cancer Statistics, 2004

@article{Jemal2004CancerS2,
  title={Cancer Statistics, 2004},
  author={A. Jemal and R. Tiwari and Taylor Murray and A. Ghafoor and Alicia Samuels and E. Ward and E. Feuer and M. Thun},
  journal={CA: A Cancer Journal for Clinicians},
  year={2004},
  volume={54}
}
  • A. Jemal, R. Tiwari, +5 authors M. Thun
  • Published 2004
  • Medicine
  • CA: A Cancer Journal for Clinicians
    • Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival rates based on incidence data from the National Cancer Institute and mortality data from the National Center for Health Statistics. Incidence and mortality rates are age standardized to the 2000 US standard million population. A total of 1,368,030 new cancer cases and 563,700… CONTINUE READING
    View on Wiley
    ncbi.nlm.nih.gov
    3,965 Citations
    Highly Influential Citations
    26
    Background Citations
    244
    Methods Citations
    5
    Results Citations
    4

    Paper Mentions

    Interventional Clinical Trial
    Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer
    The purpose of this study is to collect data and evaluate how the tumor is broken down in response to standard of care cetuximab treatment by evaluating the FDG-PET/CT scans… Expand
    ConditionsCarcinoma, Squamous Cell
    InterventionDrug, Procedure
    Washington University School of Medicine
    June 2008 - August 2015
    Interventional Clinical Trial
    Imaging Studies of Kidney Cancer Using 18F-VM4-037
    Background: - The drug 18F-VM4-037 is being tested for use in cancer imaging studies. It may help tumor tissue show up more clearly during scans. Researchers want to see how well… Expand
    ConditionsCarcinoma, Renal Cell, Kidney Neoplasms
    InterventionDrug, Procedure
    National Institutes of Health Clinical Center (CC)
    October 2012 - August 2013
    Interventional Clinical Trial
    Proton Chemoradiotherapy for High-Risk Soft Tissue Sarcomas
    The goal of this study is to evaluate the effects of temozolomide and radiation combination in the treatment intended of soft tissue sarcomas. This study will also look at the… Expand
    ConditionsSoft Tissue Sarcomas
    InterventionDrug, Procedure, Radiation
    University of Florida
    February 2009 - November 2012
    Observational Clinical Trial
    Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer
    Chemoresponse assays (lab test) measure the effect that chemotherapy treatment has on a patient's cancer cells in the lab. This test has shown success in a retrospective study in… Expand
    ConditionsFallopian Tube Cancer, Ovarian Cancer, Peritoneal Neoplasms
    Precision Therapeutics
    July 2004 - October 2012
    3,965 Citations
    Citation Type

    Citation Type

    Comparisons of prostate cancer mortality rates with dietary practices in the United States.
    • 22
    Gender Differences: Implications for Clinical Trials and Practice
    • A. Ceribelli, M. Pino, F. Cecere
    • Medicine
    • Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
    • 2007
    • 16
    Why do postmenopausal African-American women not benefit from overall breast cancer mortality decline?
    • 9
    Partial cancer prevalence in Japan up to 2020: estimates based on incidence and survival data from population-based cancer registries.
    • 23
    • PDF
    Male breast cancer: a different disease than female breast cancer?
    • A. Malani
    • Medicine
    • Southern medical journal
    • 2007
    • 11
    Lung Cancer Prevention
    International epidemiology of prostate cancer: geographical distribution and secular trends.
    • 398
    How representative are the surveillance, epidemiology, and end results (SEER) Program cancer data of the United States?
    • 67
    Ovarian Cancer Prevention
    • 7
    Incidence and outcome of male breast cancer: an international population-based study.
    • 119
    • PDF

    References

    SHOWING 1-10 OF 24 REFERENCES
    Trends in Breast Cancer by Race and Ethnicity
    • 461
    Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.
    • 850
    • PDF
    Impact of reporting delay and reporting error on cancer incidence rates and trends.
    • 238
    • PDF
    Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study.
    • 510
    • PDF
    A New Method of Predicting US and State‐Level Cancer Mortality Counts for the Current Calendar Year
    • 67
    Cancer statistics for african americans
    • 572
    Survival of blacks and whites after a cancer diagnosis.
    • 323
    Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates.
    • R. Anderson, A. Miniño, D. Hoyert, H. Rosenberg
    • Medicine
    • National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System
    • 2001
    • 599
    • PDF
    The World Health Organization.
    • 27,013
    • PDF
    International Classification of Diseases for Oncology
    • 2,682
    • PDF